MSD
The Principal Scientist in Drug Metabolism and Pharmacokinetics (DMPK) leads multi-disciplinary efforts to advance small molecule and biologics therapeutics through integrated PK/PD and drug interaction risk assessments. This role guides the design of in silico, in vitro, and in vivo analyses to support clinical development while authoring regulatory documents for filings. Key duties include mitigating program risks, mentoring staff, and collaborating with cross-functional teams to ensure efficient drug progression.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
20% above the average for this role
MSD ends takeover talks with Revolution Medicines
1 month ago